skip to content

Cambridge Centre for Neuropsychiatric Research



Psynova Neurotech Ltd (SME)

In 2005, Professor Bahn co-founded Psynova Neurotech Ltd., which, together with Rules Based Medicine (RBM) has launched the first blood test aiding in the early diagnosis of Schizophrenia. In 2011 Psynova Neurotech and RBM were acquired by Myriad Genetics, a NASDAQ listed company.